1
Focus on TB
Our product TBseq is commented by WHO Rapid Communication (2023)
2
Qualifications
Successfully passed CAP certification and China NCCL inter-laboratory quality assessment certification for several consecutive years.
3
New Technologies
Shengting Medical is the only testing institution in China that primarily uses nanopore sequencing as its clinical testing method, holding numerous related patent technologies.
4
Experienced
Shengting Medical has assisted over 80,000 tuberculosis patients and 100,000 other patients, boasting extensive clinical testing experience and reliable clinical testing technology.
--Diagnostic-Kits-(CBA)-484.jpg.webp)